Systemic rosiglitazone administration leads to cementocytes apoptosis in wild type mice (2021)
Source: Scientia Plena. Unidade: FOB
Subjects: CEMENTO DENTÁRIO, APOPTOSE, CEMENTÓCITO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, R. A. B et al. Systemic rosiglitazone administration leads to cementocytes apoptosis in wild type mice. Scientia Plena, v. 17, n. 7, 2021Tradução . . Disponível em: https://doi.org/10.14808/sci.plena.2021.076701. Acesso em: 11 jun. 2024.APA
Silva, R. A. B., Silva, L. A. B., Oliveira-Vanderlei, K. M. H., & Barbosa-Lima, R. (2021). Systemic rosiglitazone administration leads to cementocytes apoptosis in wild type mice. Scientia Plena, 17( 7). doi:10.14808/sci.plena.2021.076701NLM
Silva RAB, Silva LAB, Oliveira-Vanderlei KMH, Barbosa-Lima R. Systemic rosiglitazone administration leads to cementocytes apoptosis in wild type mice [Internet]. Scientia Plena. 2021 ; 17( 7):[citado 2024 jun. 11 ] Available from: https://doi.org/10.14808/sci.plena.2021.076701Vancouver
Silva RAB, Silva LAB, Oliveira-Vanderlei KMH, Barbosa-Lima R. Systemic rosiglitazone administration leads to cementocytes apoptosis in wild type mice [Internet]. Scientia Plena. 2021 ; 17( 7):[citado 2024 jun. 11 ] Available from: https://doi.org/10.14808/sci.plena.2021.076701
